Literature DB >> 20157632

Comparison of Isotonic Designs for Dose-Finding.

Anastasia Ivanova1, Nancy Flournoy.   

Abstract

We compare several decision rules for allocating subjects to dosages that are based on sequential isotonic estimates of a monotone dose-toxicity curve. We conclude that the decision rule in which the next assignment is to the dose having probability of toxicity closest to target does not work well. The best rule in our comparison is given by the cumulative cohort design. According to this design, the dose for the next subject is decreased, increased, or repeated depending on the distance between the estimated toxicity rate at the current dose and the target quantile.

Entities:  

Year:  2009        PMID: 20157632      PMCID: PMC2821065          DOI: 10.1198/sbr.2009.0010

Source DB:  PubMed          Journal:  Stat Biopharm Res        ISSN: 1946-6315            Impact factor:   1.452


  9 in total

1.  Improved up-and-down designs for phase I trials.

Authors:  Anastasia Ivanova; Aliakbar Montazer-Haghighi; Sri Gopal Mohanty; Stephen D Durham
Journal:  Stat Med       Date:  2003-01-15       Impact factor: 2.373

2.  Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials.

Authors:  Y Lin; W J Shih
Journal:  Biostatistics       Date:  2001-06       Impact factor: 5.899

3.  A non-parametric approach to the design and analysis of two-dimensional dose-finding trials.

Authors:  Anastasia Ivanova; Kai Wang
Journal:  Stat Med       Date:  2004-06-30       Impact factor: 2.373

4.  Designs for single- or multiple-agent phase I trials.

Authors:  Mark R Conaway; Stephanie Dunbar; Shyamal D Peddada
Journal:  Biometrics       Date:  2004-09       Impact factor: 2.571

5.  Isotonic designs for phase I cancer clinical trials with multiple risk groups.

Authors:  Zhilong Yuan; Rick Chappell
Journal:  Clin Trials       Date:  2004       Impact factor: 2.486

6.  Escalation, group and A + B designs for dose-finding trials.

Authors:  Anastasia Ivanova
Journal:  Stat Med       Date:  2006-11-15       Impact factor: 2.373

7.  Continual reassessment method: a practical design for phase 1 clinical trials in cancer.

Authors:  J O'Quigley; M Pepe; L Fisher
Journal:  Biometrics       Date:  1990-03       Impact factor: 2.571

8.  Isotonic designs for phase I trials.

Authors:  D H Leung; Y Wang
Journal:  Control Clin Trials       Date:  2001-04

9.  Bivariate isotonic design for dose-finding with ordered groups.

Authors:  Anastasia Ivanova; Kai Wang
Journal:  Stat Med       Date:  2006-06-30       Impact factor: 2.373

  9 in total
  6 in total

1.  Dose finding for continuous and ordinal outcomes with a monotone objective function: a unified approach.

Authors:  Anastasia Ivanova; Se Hee Kim
Journal:  Biometrics       Date:  2008-05-13       Impact factor: 2.571

2.  Estimating the dose-toxicity curve in completed phase I studies.

Authors:  Alexia Iasonos; Irina Ostrovnaya
Journal:  Stat Med       Date:  2011-02-22       Impact factor: 2.373

3.  Interplay of priors and skeletons in two-stage continual reassessment method.

Authors:  Alexia Iasonos; John O'Quigley
Journal:  Stat Med       Date:  2012-08-15       Impact factor: 2.373

4.  TSNP: A two-stage nonparametric phase I/II clinical trial design for immunotherapy.

Authors:  Yan Han; Hao Liu; Sha Cao; Chi Zhang; Yong Zang
Journal:  Pharm Stat       Date:  2020-10-06       Impact factor: 1.234

5.  Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicities.

Authors:  Monia Ezzalfani; Sarah Zohar; Rui Qin; Sumithra J Mandrekar; Marie-Cécile Le Deley
Journal:  Stat Med       Date:  2013-01-21       Impact factor: 2.373

Review 6.  A Brief Overview of Adaptive Designs for Phase I Cancer Trials.

Authors:  Anshul Saxena; Muni Rubens; Venkataraghavan Ramamoorthy; Zhenwei Zhang; Md Ashfaq Ahmed; Peter McGranaghan; Sankalp Das; Emir Veledar
Journal:  Cancers (Basel)       Date:  2022-03-18       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.